Measurement of blood pressure in the office: Recognizing the problem and proposing the solution

Hypertension

Volumn 55, Issue 2, 2010, Pages 195-200

  Myers, Martin G ^a   Godwin, Marshall ^d   Dawes, Martin ^e   Kiss, Alexander ^b   Tobe, Sheldon W ^c   Kaczorowski, Janusz ^f  

^a Division of Cardiology   (Canada)

^b Department of Research Design and Biostatistics ^*

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL PRACTICE; HEALTH PRACTITIONER; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MEDICAL SOCIETY; OCCUPATIONAL HEALTH; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SHORT SURVEY; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; BLOOD PRESSURE MONITORS; FEMALE; HUMANS; HYPERTENSION; MALE; OFFICE VISITS; ONTARIO; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SELF CARE;

EID: 74949121981     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.141879     Document Type: Short Survey

References (37)

1. Pickering G. High blood pressure. London: J&A Churchill Ltd; 1968:229.
2. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988;77:504-514.
3. Pickering TG, Gerin W, Schwartz JE, Spruill TM, Davidson KW. Should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens. 2008;26:2259-2267.
4. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals Part 1: blood pressure measurement in humans a statement for professionals from the subcommittee of Professional and Public Education of the Am Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-161. (Pubitemid 40066429)
5. Parati G, Omboni S, Bilo G. Why is out-of-office blood pressure measurement needed? Hypertension. 2009;54:181-187.
6. Verdecchia P, Angeli F, Mazzota G, Gentile G, Reboldi G. Home blood pressure measurements will not replace 24-hour ambulatory blood pressure monitoring. Hypertension. 2009;54:188-195.
7. Myers MG, Oh P, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens. 1995;8:591-597.
8. Brown MA, Buddle ML, Martin A Is resistant hypertension really resistant? Am J Hypertens. 2001;14:1263-1269.
9. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280-286.
10. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823-827.
11. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens. 2003;17:811-817.
12. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005;5:18.
13. Dawes MG, Coats AJ, Juszczak E. Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood Pressure Monitoring. 2006;11:111-118.
14. Sala C, Santin A, Rescaldani M, Magrini F. How long shall the patient rest before clinic blood pressure measurement? Am J Hypertens. 2006;19:713-717.
15. O'Brien E. Ambulatory blood pressure measurement: the case for implementation in primary care. Hypertension. 2008;51:1435-1441.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
17. Myers MG. Automated blood pressure measurement in routine clinical practice. Blood Pressure Monitoring. 2006;11:59-62.
18. Myers MG, Valdivieso M, Kiss A. Optimum frequency of automated blood pressure measurements using an automated sphygmomanometer. Blood Press Monit. 2008;13:333-338.
19. White WG, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6:107-110.
20. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife WatchBP Office professional device for office blood pressure measurement according to the International Protocol. Blood Press Monit. 2008;13:299-303.
21. White WB, Cleveland JM, Rolleri RL, for the Ramipril-Hydrochlorothiazide Study Group. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothia-zide Hypertension Trial. J Human Hypertens. 2008;22:559-568.
22. Mazze RS, Simonson GD, Robinson RL, Kendall DM, Idrogo MA, Adlis SA, Boyce KS, Dunne CJ, Anderson RL, Bergenstal RM. Characterizing blood pressure control in individuals with Type 2 diabetes: The relationship between clinic and self-monitored blood pressure. Diabet Med. 2003;20:752-757.
23. Mazze RS, Robinson R, Simonson G, Idrogo M, Simpson B, Kendall D, Bergenstal R. Undetected, uncontrolled blood pressure in Type 2 Diabetes: Self-monitored blood pressure profiles. Blood Pressure. 2004;13:335-342.
24. Nelson MR, Quinn S, Bowers-Ingram L, Nelson JM, Winzenberg TM. Cluster-randomized controlled trial of oscillometric vs. manual sphygmo-manometer for blood pressure management in primary care (CRAB). Am J Hypertens. 2009;22:598-603.
25. Dahlöf B, Sever PS, PoulterNR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ö stergren J, for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding ben-droflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a mul-ticenter randomized controlled trial. Lancet. 2005;366:907-913.
26. Ishikawa J. Nasothimiou E, Karpettas N, Feltheimer S, McDoniel S, Schwartz J Stergiou G, Pickering T. Automatic office blood pressure measurement without doctors or nurses present is more predictive of ambulatory blood pressure than is office blood pressure by mercury sphygmomanometer. J Hypertens. 2009;27(Suppl 4):S170.
27. Bailey RH, Bauer JH. A review of common errors in the indirect measurement of blood pressure. Arch Int Med. 1993;153:2741-2748.
28. Le Pailleur C, Helft G, Landais P, Montgermont P, Feder JM, Metzger JP, Vacheron A. The effects of talking, reading, and silence on the 'white coat' phenomenon in hypertensive patients. Am J Hypertens. 1998;11:203-207.
29. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension. 1987;9:209-215.
30. Myers MG, Dawes M, Godwin M, Kaczorowski J, Kiss A, Tobe SW Minimum number of readings for automated office blood pressure measurement. J Hypertens. 2009;27(Suppl 4):S197.
31. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit. 2009;14:108-111.
32. Kaczorowski J, Chambers LW, Karwalajtys T, Dolovich L, Farrell B, McDonough B, Sebaldt R, Levitt C, Hogg W, Thabane L, Tu K, Goeree R, Paterson JM, Shubair M, Gierman T, Sullivan S, Carter M. Cardiovascular health awareness program (CHAP): A community cluster-randomised trial among elderly Canadians. Prevent Med. 2008;46:537-544.
33. Leenen FHH, Dumais J, McInnis N, Turton P, Stratychuk L, Nemeth K, Lum-Kwong Mm, Fodor G. 2006 Ontario survey on the prevalence and control of hypertension (ON BP). CMAJ. 2008;178:1441-1449.
34. Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens. 2008;21:280-283.
35. Ostchega Y, Nwankwo T, Sorlie PD, Wolz M, Zipf G. Assessing the validity of the Omron HEM-907XL oscillometric blood pressure measurement device in a national survey environment. J Clin Hypertens. In press.
36. Myers MG. A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J Hypertens. In press.
37. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51:55-61.